Status:
COMPLETED
Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Brief Summary
The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. ...
Eligibility Criteria
Inclusion
- Main inclusion criteria:
- History of persistent bronchial asthma
- Main exclusion criteria:
- Hypersensitive to compounds of Alvesco
- Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT00608218
Start Date
January 1 2008
End Date
August 1 2008
Last Update
December 5 2016
Active Locations (153)
Enter a location and click search to find clinical trials sorted by distance.
1
"Nycomed Deutschland GmbH"
Adendorf, Germany, 21365
2
"Nycomed Deutschland GmbH"
Arnstadt, Germany, 99310
3
"Nycomed Deutschland GmbH"
Auerbach, Germany, 08209
4
"Nycomed Deutschland GmbH"
Augsburg, Germany, 86150